[ET Net News Agency, 1 November 2019] Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,
Ltd. (01349) said its profit attributable to shareholders of the company was RMB118.34
million for the nine months ended 30 September 2019, a year-on-year increase of 40.84%.
The revenue was RMB624.85 million, a year-on-year increase of 27.76%. (RC)